Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.68 |
| ▸ | CHRNA10 | Q9GZZ6 | 2/20 | 0.68 |
| ▸ | CHRNA9 | Q9UGM1 | 2/20 | 0.68 |
| ▸ | CHKA | P35790 | 3/20 | 0.57 |
| ▸ | HTT | P42858 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4405443 | 0.89 | HTT (0.61) | CHRNA7CHRNA10CHRNA9CHKAHTT | |
| SCHEMBL13334229 | 0.88 | CHRNA7 (0.55) | CHRNA7CHRNA10CHRNA9CHKAHTT | |
| Bromide SCHEMBL3313967 | 0.87 | CHRNA7 (0.56) | CHRNA7CHRNA10CHRNA9CHKAHTT | |
| SCHEMBL5292316 | 0.86 | KDM4E (0.53) | CHRNA7CHRNA10CHRNA9CHKAHTT | |
| SCHEMBL13334099 | 0.82 | HTT (0.69) | CHRNA7CHRNA10CHRNA9CHKAHTT | |
| SCHEMBL4404376 | 0.82 | CHKA (0.65) | CHRNA7CHRNA10CHRNA9CHKAHTT | |
| Bromide SCHEMBL3314015 | 0.81 | HTT (0.67) | CHRNA7CHRNA10CHRNA9CHKAHTT | |
| SCHEMBL4398944 | 0.81 | CHRNA7 (1.00) | CHRNA7CHRNA10CHRNA9CHKAHTT | |
| SCHEMBL13361695 | 0.80 | HTT (0.60) | CHRNA7CHRNA10CHRNA9CHKAHTT | |
| SCHEMBL4403538 | 0.80 | HTT (0.50) | CHRNA7CHRNA10CHRNA9CHKAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178678-B2 | Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2012-05-15 | — | — | US | disclosed |
| US-20100069432-A1 | Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069432-A1 | Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | CHRNA2, CHRNA5, CHRNA4 | CHRNA7 7/4885CHRNA10 4/4885CHRNA9 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.